Aptevo Therapeutics
Seattle, US
Biotech
Founders & leadership
ML
Marvin L WhiteExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$2.1MraisedApr 2025 · 11 investors · Pharmaceuticals
Rule 506(c)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.